Identification of phenotype-relevant differentially expressed genes in breast cancer demonstrates enhanced quantile discretization protocol's utility in multi-platform microarray data integration

No abstract is available for this paper.

• Publication year

  2016

• Venue

  J. Bioinform. Comput. Biol.

• Publication date

  2016-11-03

• Fields of study

  Biology, Mathematics, Computer Science, Medicine

• Identifiers
  DOI 10.1142/S0219720016500220PMID 27411306
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Abstract 2168: Dual targeting of the AKT/mTOR signaling pathwayinhibits mesothelioma: Targeted therapies against multiple activated receptor tyrosine kinases.

  2013cited by this paper
• Eukaryotic initiation factor 4F: a vulnerability of tumor cells.

  2012cited by this paper
• Comprehensive literature review and statistical considerations for microarray meta-analysis

  2012cited by this paper
• Dual targeting of the Akt/mTOR signaling pathway inhibits castration-resistant prostate cancer in a genetically engineered mouse model.

  2012cited by this paper
• Translation regulation as a therapeutic target in cancer.

  2012cited by this paper
• Translational control in cancer etiology.

  2012cited by this paper
• Meta-analysis of multiple microarray datasets reveals a common gene signature of metastasis in solid tumors

  2011cited by this paper
• Translational control gone awry: a new mechanism of tumorigenesis and novel targets of cancer treatments.

  2011cited by this paper
• Inhibitors of the PI3K/Akt/mTOR pathway: new hope for breast cancer patients.

  2010cited by this paper
• Down‐regulation of Notch‐1 and Jagged‐1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF‐κB signaling pathways

  2010cited by this paper
• RETRACTED ARTICLE: FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factors

  2010cited by this paper
• Translational control in cancer

  2010cited by this paper
• Cross-platform microarray data integration using the Normalised Linear Transform

  2010cited by this paper
• Mechanisms governing the control of mRNA translation

  2010cited by this paper
• Should We Abandon the t-Test in the Analysis of Gene Expression Microarray Data: A Comparison of Variance Modeling Strategies

  2010cited by this paper
• Molecular mechanisms of mTOR-mediated translational control

  2009cited by this paper
• Microarray data analysis for differential expression: a tutorial.

  2009cited by this paper
• Cell cycle, CDKs and cancer: a changing paradigm

  2009cited by this paper
• Targeting PI3K signalling in cancer: opportunities, challenges and limitations

  2009cited by this paper
• Merging two gene-expression studies via cross-platform normalization

  2008cited by this paper
• Current overview of the role of Akt in cancer studies via applied immunohistochemistry.

  2008cited by this paper
• Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy.

  2007cited by this paper
• Targeting Akt in cancer therapy.

  2007cited by this paper
• Individual Overexpression of Five Subunits of Human Translation Initiation Factor eIF3 Promotes Malignant Transformation of Immortal Fibroblast Cells*

  2007cited by this paper
• Initiation factor eIF3 and regulation of mRNA translation, cell growth, and cancer.

  2006cited by this paper
• AKT and cancer--is it all mTOR?

  2006cited by this paper
• Microarray analysis and tumor classification.

  2006cited by this paper
• Telomerase inhibition in cancer therapeutics: molecular-based approaches.

  2006cited by this paper
• Molecular mechanisms of resistance to therapies targeting the epidermal growth factor receptor.

  2005cited by this paper
• AVID: An integrative framework for discovering functional relationships among proteins

  2005cited by this paper
• Cross-platform analysis of cancer microarray data improves gene expression based classification of phenotypes

  2005cited by this paper
• Joint analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes

  2004cited by this paper
• Akt Phosphorylation and Stabilization of X-linked Inhibitor of Apoptosis Protein (XIAP)*

  2004cited by this paper
• Are data from different gene expression microarray platforms comparable?

  2004cited by this paper
• Bioconductor: open software development for computational biology and bioinformatics

  2004cited by this paper
• Pathways of apoptotic and non-apoptotic death in tumour cells

  2004cited by this paper
• Multiple Hypothesis Testing in Microarray Experiments

  2003cited by this paper
• Resampling-based multiple testing for microarray data analysis

  2003cited by this paper
• The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer

  2003cited by this paper
• Nonparametric methods for identifying differentially expressed genes in microarray data

  2002cited by this paper
• Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer.

  2001cited by this paper
• The protein kinase PKB/Akt regulates cell survival and apoptosis by inhibiting Bax conformational change

  2001cited by this paper
• Delineation of prognostic biomarkers in prostate cancer

  2001cited by this paper
• The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal.

  1997cited by this paper

• Cross-Platform in-silico Analyses Exploring Tumor Immune Microenvironment with Prognostic Value in Triple-Negative Breast Cancer

  2022cites this paper
• A meta-analysis of public microarray data identifies gene regulatory pathways deregulated in peripheral blood mononuclear cells from individuals with Systemic Lupus Erythematosus compared to those without

  2016cites this paper